Docoh
Loading...

BTTX Better Therapeutics

News

From Benzinga Pro
68 Biggest Movers From Wednesday
26 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share.
Mid-Day Market Update: Gap Drops Following Downbeat Q3 Results; Ocuphire Pharma Shares Jump
24 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets
Midway through trading Wednesday, the Dow traded down 0.28% to 35,714.19 while the NASDAQ fell 0.29% to 15,729.96. The S&P also fell, dropping 0.20% to 4,681.42.
40 Stocks Moving In Wednesday's Mid-Day Session
24 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Biofrontera Inc. (NASDAQ: BFRI) shares jumped 109.5% to $5.51 after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target.
Mid-Morning Market Update: Markets Open Lower; Deere Earnings Top Views
24 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Following the market opening Wednesday, the Dow traded down 0.30% to 35,706.59 while the NASDAQ fell 0.61% to 15,678.70. The S&P also fell, dropping 0.34% to 4,674.85.
Benzinga's Top Ratings Upgrades, Downgrades For November 24, 2021
24 Nov 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Chardan Capital Initiates Coverage On Better Therapeutics with Buy Rating, Announces Price Target of $17
24 Nov 21
News, Price Target, Initiation, Analyst Ratings
Chardan Capital analyst Keay Nakae initiates coverage on Better Therapeutics (NASDAQ:BTTX) with a Buy rating and announces Price Target of $17.
Better Therapeutics Completes Enrollment Of Pivotal Trial For BT-001, A Prescription Digital Therapeutic For Type 2 Diabetes
18 Nov 21
Biotech, News, FDA, General
Better Therapeutics, Inc. (("Better Therapeutics", NASDAQ:BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today
70 Biggest Movers From Yesterday
16 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
41 Stocks Moving In Monday's Mid-Day Session
15 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Casper Sleep Inc. (NYSE: CSPR) shares climbed 87.1% to $6.64 after the company agreed to be acquired by Durational Capital Management. The company also reported Q3 earnings results.
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2021
10 Nov 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Cowen & Co. Initiates Coverage On Better Therapeutics with Outperform Rating
10 Nov 21
News, Initiation, Analyst Ratings
Cowen & Co. analyst Charles Rhyee initiates coverage on Better Therapeutics (NASDAQ:BTTX) with a Outperform rating.
92 Biggest Movers From Friday
8 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
24 Stocks Moving in Thursday's Pre-Market Session
4 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Evaxion Biotech A/S (NASDAQ: EVAX) rose 143.5% to $15.83 in pre-market trading after dropping over 10% on Wednesday.
71 Biggest Movers From Yesterday
3 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Avis Budget Group, Inc. (NASDAQ: CAR) shares climbed 108.3% to close at $357.17 on Tuesday after the company reported better-than-expected Q3 adjusted EPS and sales results and added $1 billion to its buyback.
51 Stocks Moving In Tuesday's Mid-Day Session
2 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Avis Budget Group, Inc. (NASDAQ: CAR) surged 83.9% to $315.37 after the company reported better-than-expected Q3 adjusted EPS and sales results and added $1 billion to its buyback.
Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Nov. 2, 2021: TSLA, SBEA, VRAR, WIMI, BTTX
2 Nov 21
Pre-Market Outlook
Today's 5 Stock Ideas: Tesla (TSLA) - Tesla bear Gordon Johnson on Monday told Benzinga he thinks a Tesla stock split is "highly likely." Early Tuesday, Tesla bull Gene Munster told Benzinga he
24 Stocks Moving in Tuesday's Pre-Market Session
2 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Baosheng Media Group Holdings Limited (NASDAQ: BAOS) rose 119% to $3.43 in pre-market trading after declining 3% on Monday. The company, last month, swung to a loss in the first half of the year.
64 Biggest Movers From Yesterday
2 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the company filed a mixed shelf offering on Friday after the close.
Mid-Afternoon Market Update: loanDepot Surges After Q3 Results; Mirati Therapeutics Shares Slide
1 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Monday, the Dow traded up 0.12% to 35,863.70 while the NASDAQ rose 0.18% to 15,525.52. The S&P, however, fell 0.10% to 4,600.81.
Mid-Day Market Update: Dow Rises 50 Points; ANI Pharmaceuticals Shares Jump
1 Nov 21
Earnings, News, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Midway through trading Monday, the Dow traded up 0.14% to 35,871.27 while the NASDAQ rose 0.23% to 15,534.49. The S&P also fell, dropping 0.03% to 4,603.98.

Press releases

From Benzinga Pro
Better Therapeutics Completes Enrollment of Pivotal Trial for BT-001, a Prescription Digital Therapeutic for Type 2 Diabetes
18 Nov 21
Press Releases
Primary endpoint data expected in Q1 2022 Better Therapeutics, Inc. (("Better Therapeutics", NASDAQ:BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes
Better Therapeutics Appoints Major General Elder Granger, M.D., U.S. Army (retired) to its Board of Directors
11 Nov 21
Press Releases
Better Therapeutics, Inc. (("Better Therapeutics", NASDAQ:BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today
Better Therapeutics Appoints Thiago Licias de Oliveira as Its Chief People Officer
4 Nov 21
Press Releases
Better Therapeutics, Inc. (("Better Therapeutics", NASDAQ:BTTX), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today
Better Therapeutics Closes Business Combination and Debuts on Nasdaq
29 Oct 21
Press Releases
Trading to commence on Nasdaq on Oct. 29, 2021, under the ticker symbol BTTX Better Therapeutics, Inc., a prescription digital therapeutics (PDT) company delivering cognitive behavioral therapy to address the root
Mountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better Therapeutics Inc.
27 Oct 21
M&A, News, Press Releases
NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ:MCAD) (the "Company"), a publicly traded special purpose acquisition company, announced today that in a special meeting of
Mountain Crest Acquisition Corp. II and Better Therapeutics, Inc. Announce Registration Statement Effectiveness and Scheduled Special Meeting to Approve Business Combination on October 27, 2021
12 Oct 21
M&A, News, Press Releases
NEW YORK and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ:MCAD, "Mountain Crest II")), a publicly-traded special purpose acquisition company and Better Therapeutics, Inc.
Moore Kuehn Encourages EBMT, ESBK, BCML, and MCAD Investors to Contact Law Firm
7 Oct 21
News, Legal, Press Releases
NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the
Better Therapeutics to Participate in Lake Street's 5th Annual Best Ideas Growth (BIG5) Conference on September 14-15, 2021
10 Sep 21
Press Releases
Better Therapeutics, Inc. ("Better Therapeutics"), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, has been invited to